Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This appears to be a minor maintenance update to the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe page displays a new revision label indicating v3.6.4, replacing the previous v3.6.3. This change represents a software version update and does not modify the study data or visible content.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe study documents now show Revision: v3.6.3, updating from v3.6.2. This indicates an updated protocol/document for the trial.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision changed from v3.6.0 to v3.6.2 on the page, reflecting a newer software release. It is a minor patch update and does not modify the study content or public-facing information.SummaryDifference0.0%

- Check56 days agoChange DetectedThe Locations data were removed, eliminating the list and count of trial sites for this study. This removes a key navigational element that helps users identify where the trial is conducted.SummaryDifference16%

- Check63 days agoChange DetectedEnrollment status on the page now shows 'No longer looking for participants', indicating that recruitment has closed. The page also adds new help/guide sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with the revision tag to v3.6.0.SummaryDifference0.1%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.